Results 241 to 250 of about 56,186 (320)

Red Wine as an Aromatase Inhibitor: A Narrative Review. [PDF]

Cureus
Pergolizzi J, LeQuang JAK, Wagner M, Salah R, Magnusson P, Varrassi G.   +5 more
europepmc   +1 more source

A case of diffuse infiltrative liver metastases of breast cancer with severe jaundice successfully treated with aromatase inhibitor

, 2014
Munefumi Tomomatsu, Masahiro Kishimoto, Hiroya Iida, Shinichi Ikuta, Tsukasa Aihara, Hidenori Yanagi, Ayako Kakuno, Kyoko Ikeuchi, Naoki Yamanaka   +8 more
openalex   +2 more sources

Duration of aromatase inhibitor use and long-term cardiovascular risk in breast cancer survivors. [PDF]

JNCI Cancer Spectr
Huang Y, Kwan ML, Heckbert SR, Smith NL, Othus M, Laurent CA, Roh JM, Rillamas-Sun E, Lee VS, Kolevska T, Cheng RK, Irribarren C, Nguyen-Huynh M, Hershman DL, Kushi LH, Greenlee H.   +15 more
europepmc   +1 more source

Dalpiciclib plus aromatase inhibitor versus neoadjuvant chemotherapy for ER-positive, HER2-negative breast cancer. [PDF]

Front Oncol
Wang H, Zhang G, Gao W, Li S, Yang S, Zhang X, Wang J, Li C, Gao S, Geng C.   +9 more
europepmc   +1 more source

Yi Shen Tiao Gan decoction alleviates aromatase inhibitor-related bone loss by promoting H-type vessel formation. [PDF]

Transl Oncol
Chu M, Zhang Y, Ye M, Yin Y, Chen H.
europepmc   +1 more source

Steroidal Aromatase Inhibitor [PDF]

, 2020
openaire   +1 more source

A detailed transcriptome study uncovers the epigenetic characteristics associated with Aromatase inhibitor-induced masculinization in Takifugu rubripes larvae gonads. [PDF]

BMC Genomics
Shen X, Yan H, Hu M, Zhou H, Zhang Q, Gao R, Liu Q, Sun Q.   +7 more
europepmc   +1 more source

Treatment Modalities for Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS): A Scoping Review of Prospective Treatment Studies. [PDF]

J Pain Res
Bobo JA, Lubrano B, Rosario-Concepcion R, Cuartas-Abril A, Advani P, Chumsri S, Bruce BK.   +6 more
europepmc   +1 more source

Real-world progression-free survival of CDK4/6 inhibitors plus an aromatase inhibitor in HR-positive/HER2-negative metastatic breast cancer in United States routine clinical practice. [PDF]

ESMO Open
Rugo HS, Layman RM, Lynce F, Liu X, Li B, McRoy L, Cohen AB, Estevez M, Curigliano G, Brufsky A.   +9 more
europepmc   +1 more source

Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial. [PDF]

JCO Precis Oncol
Agrawal YN, Fernández-Martínez A, Gil-Gil M, Zielinski C, Ruiz-Borrego M, Ciruelos EM, Muñoz M, Margelí M, Bermejo B, Antón A, Kahan Z, Csöszi T, Alonso-Romero JL, García-Saenz JÁ, Sánchez-Rovira P, Álvarez E, Chacón JI, González-Santiago S, Rodríguez CA, Servitja S, Pfefferle AD, Herranz J, Liu Y, Carey LA, Romero-Camarero I, Caballero R, Guerrero-Zotano Á, Perou CM, Martín M.   +28 more
europepmc   +1 more source